看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。/ K) z# X l3 A. X+ R" [
4 Y& k, \8 Z6 p* o- T
# P0 x$ i# v" [9 p6 e) W6 Q2 f
Currently available feasibility data for possible combination strategies. 5 ^, Z" K5 b0 e8 u
————————————————————————————————
* I9 U2 Z i0 ~8 L" v0 zCombination Feasibility according to preliminary data
7 b$ i6 c" Y" e+ g' [——————————————————————————————————
6 Y9 h, y+ n" k. N8 P4 c4 l# WBevacizumab + sorafenib Yes, reduced dose
+ Q1 q# i+ F5 LBevacizumab + sunitinib† No
, t1 A* w& w# M$ ^$ [Bevacizumab + temsirolimus Yes
6 W' Z0 n+ X; U1 e0 Y& CBevacizumab + everolimus Yes
5 K5 J8 |: v6 H/ q4 H! S# VSorafenib + sunitinib ? ! t) S9 _: b; ]) D8 O6 u) A
Sorafenib + temsirolimus Yes, reduced dose
9 I2 s. e0 E/ W$ E7 R' W6 ?Sorafenib + everolimus Yes, reduced dose & e1 ?0 a1 z; Y) i
Sunitinib + temsirolimus† No
5 T ]! k- b3 k& C) V' s) U0 NSunitinib + everolimus ?
4 e( Q: M' d: n4 M4 dTemsirolimus + everolimus ?
, D- Y' o! K8 N" X; T: }$ r; U————————————————————
K0 z# H' f; M, z' X; F†Led to US FDA warning.# `; u' C/ g7 s. }# `1 z" c' n
?: As yet unattempted combination.: z' _+ s0 Q7 q, f& L6 M
|